(Q41225277)

2

1 reference

28 September 2017

Thorley BR

3

1 reference

28 September 2017

McKenzie IF

4

1 reference

28 September 2017

Loveland BE

European Journal of Immunology

5

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

28 September 2017

1 reference

28 September 2017

26

1 reference

28 September 2017

578-585

1 reference

28 September 2017

3

1 reference

28 September 2017

The role of C5a and antibody in the release of heparan sulfate from endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Biological effects of the human complement fragments C5a and C5ades Arg on neutrophil function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Alternative complement pathway activation increases mortality in a model of burn injury in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Human genes for three complement components that regulate the activation of C3 are tightly linked

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Decay-accelerating factor: biochemistry, molecular biology, and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Complement receptor is an inhibitor of the complement cascade

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Complement Ligand-Receptor Interactions that Mediate Biological Responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Membrane complement receptors specific for bound fragments of C3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Regulation of complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Rapid expression of an anti-human C5 chimeric Fab utilizing a vector that replicates in COS and 293 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Hu Ly-m5: A unique antigen physically associated with HLA molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Calculation of protein extinction coefficients from amino acid sequence data

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Regulatory system of guinea-pig complement C3b: Tests for compatibility of guinea-pig factors H and I with human factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

The mechanism of discordant xenograft rejection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021

Characterization and function of T cell Fc gamma receptor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260312

7 January 2021